In the FTC’s first merger challenge of the new administration, the FTC voted 4-0 last week to challenge the proposed ...
On March 6, 2025, the Federal Trade Commission (FTC) filed a lawsuit in federal court challenging GTCR BC Holdings, LLC's (GTCR) proposed ...
GlobalData on MSN3d
FTC sues to block GTCR’s ‘unlawful acquisition’ of SurmodicsGTCR already owns the second largest medical device coatings manufacturer, Biocoat, and the FTC holds market monopoly ...
Surmodics, Inc. (Nasdaq: SRDX), a provider of medical device and in vitro diagnostic technologies to the healthcare industry, ...
The regulator says the proposed merger would give the combined company more than 50% of the market for a type of medical ...
The FTC said merging Surmodics with Biocoat, where GTCR has a majority stake, would result in one company with more than 50% ...
Zacks Investment Research on MSN5d
SRDX Stock Falls Following Plan for Legal Action Against FTC ChallengeSurmodics, Inc. SRDX recently provided a statement in response to the U.S. Federal Trade Commission (“FTC”) blocking the ...
The Federal Trade Commission sued Thursday to block private equity firm GTCR BC Holdings’ acquisition of Surmodics Inc., ...
The Federal Trade Commission on March 6 sued to block GTCR’ s acquisition of Surmodics, alleging that “the deal, which seeks to combine the two largest manufacturers of critical medical device ...
Surmodics stock drops 4.76% in premarket trading following news that the FTC will challenge its proposed acquisition by GTCR.
The agency is challenging the deal, citing antitrust concerns due to GTCR's existing ownership of Surmodics' rival Biocoat.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback